Scopolamine induced learning failures in man
- PMID: 406632
- DOI: 10.1007/BF00426713
Scopolamine induced learning failures in man
Abstract
Two experiments were performed to determine the locus of the amnestic effects of scopolamine in man. The first experiment involved 24 volunteers receiving one of three doses of scopolamine (5, 8 or 10 microng/kg) or a placebo, intravenously. The subjects were tested for retention of material learned prior to administration of the drug, acquisition of new information, and retention of material learned while under the influence of the drug. Results indicated that scopolamine has its primary effect on the acquisition of new material and less of an effect on the retrieval of information already learned. The second experiment was designed to refine and expand upon the results of the first and involved 18 volunteers receiving eith 5 or 10 microng/kg of scopolamine or a placebo, intravenously. The subjects were given four trials to learn a list of verbal materials, and their recall for that material was measured at various intervals up to 24 h. These results confirmed those of the first experiment in that the predominant influence of the drug was to impair the acquisition of new information. Implications of these results for memory mechanisms are discussed.
Similar articles
-
Scopolamine state-dependent memory processes in man.Psychopharmacology (Berl). 1979 Sep;64(3):309-14. doi: 10.1007/BF00427515. Psychopharmacology (Berl). 1979. PMID: 116273 Clinical Trial.
-
Effects of scopolamine on verbal memory; a retrieval or acquisition deficit?Neuropsychobiology. 1989;21(2):76-83. doi: 10.1159/000118556. Neuropsychobiology. 1989. PMID: 2693994 Clinical Trial.
-
An evaluation of the mechanism of scopolamine-induced impairment in two passive avoidance protocols.Pharmacol Biochem Behav. 1988 Jan;29(1):15-21. doi: 10.1016/0091-3057(88)90267-5. Pharmacol Biochem Behav. 1988. PMID: 3353420
-
Studies on human memory: the interactions of diazepam, scopolamine, and physostigmine.Psychopharmacology (Berl). 1977 Mar 23;52(1):1-6. doi: 10.1007/BF00426592. Psychopharmacology (Berl). 1977. PMID: 403551 Clinical Trial.
-
Effects of scopolamine on learning and memory in monkeys.Psychopharmacology (Berl). 1996 Jan;123(1):9-14. doi: 10.1007/BF02246275. Psychopharmacology (Berl). 1996. PMID: 8741949
Cited by
-
Central administration of afzelin extracted from Ribes fasciculatum improves cognitive and memory function in a mouse model of dementia.Sci Rep. 2021 Apr 28;11(1):9182. doi: 10.1038/s41598-021-88463-6. Sci Rep. 2021. PMID: 33911138 Free PMC article.
-
Effects of physostigmine on memory test performance in normal volunteers.Psychopharmacology (Berl). 1986;90(3):364-6. doi: 10.1007/BF00179192. Psychopharmacology (Berl). 1986. PMID: 3097725
-
Age-related decline in central cholinergic function demonstrated with scopolamine.Psychopharmacology (Berl). 1996 May;125(1):50-6. doi: 10.1007/BF02247392. Psychopharmacology (Berl). 1996. PMID: 8724448 Clinical Trial.
-
Cholinergic blockade reveals role for human hippocampal theta in encoding but not retrieval.bioRxiv [Preprint]. 2025 May 12:2025.05.12.653487. doi: 10.1101/2025.05.12.653487. bioRxiv. 2025. PMID: 40463111 Free PMC article. Preprint.
-
The cholinergic system in the pathophysiology and treatment of Alzheimer's disease.Brain. 2018 Jul 1;141(7):1917-1933. doi: 10.1093/brain/awy132. Brain. 2018. PMID: 29850777 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources